Open access · CC-BY
via OpenAlex
Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections
Robert Thänert, Anna Thänert, Jocelyn Ou, Adam Bajinting, Carey‐Ann D. Burnham, Holly J. Engelstad, Maria E. Tecos, I. Malick Ndao, Carla M. Hall-Moore, Colleen Rouggly-Nickless, Mike A. Carl, Deborah C. Rubin, Nicholas O. Davidson, Phillip I. Tarr, Barbara B. Warner
Gut Microbes · 2021 · ▲ 35 citations
Abstract
Surgical removal of the intestine, lifesaving in catastrophic gastrointestinal disorders of infancy, can result in a form of intestinal failure known as short bowel syndrome (SBS). Bloodstream infections (BSIs) are a major challenge in pediatric SBS management. BSIs require frequent antibiotic therapy, with ill-defined consequences for the gut microbiome and childhood health. Here, we combine serial stool collection, shotgun metagenomic sequencing, multivariate statistics and genome-resolved strain-tracking in a cohort of 19 patients with surgically-induced SBS to show that antibiotic-driven intestinal dysbiosis in SBS enriches for persistent intestinal colonization with BSI causative pathogens in SBS. Comparing the gut microbiome composition of SBS patients over the first 4 years of life to 19 age-matched term and 18 preterm controls, we find that SBS gut microbiota diversity and composition was persistently altered compared to controls. Commensals including Ruminococcus, Bifidobacterium, Eubacterium, and Clostridium species were depleted in SBS, while pathobionts (Enterococcus) were enriched. Integrating clinical covariates with gut microbiome composition in pediatric SBS, we identified dietary and antibiotic exposures as the main drivers of these alterations. Moreover, antibiotic resistance genes, specifically broad-spectrum efflux pumps, were at a higher abundance in SBS, while putatively beneficial microbiota functions, including amino acid and vitamin biosynthesis, were depleted. Moreover, using strain-tracking we found that the SBS gut microbiome harbors BSI causing pathogens, which can persist intestinally throughout the first years of life. The association between antibiotic-driven gut dysbiosis and enrichment of intestinal pathobionts isolated from BSI suggests that antibiotic treatment may predispose SBS patients to infection. Persistence of pathobionts and depletion of beneficial microbiota and functionalities in SBS highlights the need for microbiota-targeted interventions to prevent infection and facilitate intestinal adaptation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1080/19490976.2021.1940792
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Thänert, R., Thänert, A., Ou, J., Bajinting, A., Burnham, C.D., Engelstad, H.J., Tecos, M.E., Ndao, I.M., Hall-Moore, C.M., Rouggly-Nickless, C., Carl, M.A., Rubin, D.C., Davidson, N.O., Tarr, P.I., Warner, B.B., Dantas, G.A., & Warner, B.W. (2021). Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections. <em>Gut Microbes</em>. https://doi.org/10.1080/19490976.2021.1940792
Vancouver
Thänert R, Thänert A, Ou J, Bajinting A, Burnham CD, Engelstad HJ, et al. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections. Gut Microbes. 2021. doi:10.1080/19490976.2021.1940792.
BibTeX
@article{robert2021Antibi,
title = {Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections},
author = {Robert Thänert and Anna Thänert and Jocelyn Ou and Adam Bajinting and Carey‐Ann D. Burnham and Holly J. Engelstad and Maria E. Tecos and I. Malick Ndao and Carla M. Hall-Moore and Colleen Rouggly-Nickless and Mike A. Carl and Deborah C. Rubin and Nicholas O. Davidson and Phillip I. Tarr and Barbara B. Warner and Gautam A. Dantas and Brad W. Warner},
journal = {Gut Microbes},
year = {2021},
doi = {10.1080/19490976.2021.1940792},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alimentary Pharmacology & Therapeutics 2017
Open access · OA
Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications
Clinical and Translational Gastroenterology 2020
Open access · CC-BY
The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens
Biomedicines 2022
Open access · CC-BY
Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp.
Clinical Infectious Diseases 2018
Open access · OA
Gut Dysbiosis Associated With Hepatitis C Virus Infection
The ISME Journal 2015
Open access · CC-BY
The initial state of the human gut microbiome determines its reshaping by antibiotics
Frontiers in Cellular and Infection Microbiology 2021
Open access · CC-BY